Ameritas Investment Partners’s Agilon Health AGL Stock Holding History

Ameritas Investment Partners’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$121K	Sell	1,131 -77	-6%	-$5.04K	﹤0.01%	1702
2026 Q1	$9.55K	Sell	1,208 -1	-0.1%	-$16	﹤0.01%	2884
2025 Q4	$20.8K	Hold	1,209	–	–	﹤0.01%	2617
2025 Q3	$31.1K	Hold	1,209	–	–	﹤0.01%	2459
2025 Q2	$69.5K	Hold	1,209	–	–	﹤0.01%	1976
2025 Q1	$131K	Hold	1,209	–	–	﹤0.01%	1527
2024 Q4	$57.4K	Hold	1,209	–	–	﹤0.01%	2099
2024 Q3	$119K	Hold	1,209	–	–	﹤0.01%	1675
2024 Q2	$198K	Buy	+1,209	New	+$172K	0.01%	1271

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ameritas Investment Partners's AGL Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Agilon Health (AGL) stake by 6.4% in Q2 2026, selling an estimated $5.04K and leaving 1,131 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

Ameritas Investment Partners first reported a position in AGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $198K in Q2 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Ameritas Investment Partners held 1,131 shares of Agilon Health worth $121K as of Q2 2026.
Ameritas Investment Partners sold 77 Agilon Health shares in Q2 2026, an estimated $5.04K.
Agilon Health made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1702 holding.
Ameritas Investment Partners first reported a position in Agilon Health in Q2 2024 and has held it in 9 quarters since.
Ameritas Investment Partners's Agilon Health position peaked at $198K in Q2 2024.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.